A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
type: MedicalStudy
description: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2006-09
end date: 2007-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00382408
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Duramed Research
study subject: Respiratory Tract Diseases
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Respiratory Tract Diseases

AI Analytics
type: Organization